The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence

Background and Purpose Non-high-density lipoprotein cholesterol (non-HDL-C), which represents the total cholesterol content of all pro-atherogenic lipoproteins, has recently been included as a new target for lipid-lowering therapy in high-risk atherosclerotic patients in multiple guidelines. Herein,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Qin Xu, Xia Meng, Hao Li, Xuewei Xie, Jing Jing, Jinxi Lin, Yong Jiang, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Anxin Wang, Yongjun Wang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Korean Stroke Society 2024-05-01
Saila:	Journal of Stroke
Gaiak:	chance-2 stroke ticagrelor clopidogrel non–high-density lipoprotein cholesterol
Sarrera elektronikoa:	http://www.j-stroke.org/upload/pdf/jos-2024-00367.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!